Freestone Grove Partners LP Dexcom Inc Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Dexcom Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,254 shares of DXCM stock, worth $188,927. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,254Holding current value
$188,927% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,091Shares Held
445MCall Options Held
6.78MPut Options Held
7.25M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct69.2MShares$4.01 Billion2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...